Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16708051rdf:typepubmed:Citationlld:pubmed
pubmed-article:16708051lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C2347610lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C0045093lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C1335648lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:16708051lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:16708051pubmed:issue6lld:pubmed
pubmed-article:16708051pubmed:dateCreated2006-5-18lld:pubmed
pubmed-article:16708051pubmed:abstractTextSignificant variability in the efficacy and toxicity of an anticancer drug is observed in cancer patients. Currently, there are no standard tools for prediction of a patient's tumor response or his risk of adverse events to chemotherapy.lld:pubmed
pubmed-article:16708051pubmed:languageenglld:pubmed
pubmed-article:16708051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:citationSubsetIMlld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16708051pubmed:statusMEDLINElld:pubmed
pubmed-article:16708051pubmed:monthJunlld:pubmed
pubmed-article:16708051pubmed:issn1744-6872lld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:ParkKyu...lld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:KimTae SooTSlld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:RhaSun...lld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:ChungHyun...lld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:JeungHei-Cheu...lld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:ChoiYeon HoYHlld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:KwonWoo SunWSlld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:LeeJung OkJOlld:pubmed
pubmed-article:16708051pubmed:authorpubmed-author:JungJae...lld:pubmed
pubmed-article:16708051pubmed:issnTypePrintlld:pubmed
pubmed-article:16708051pubmed:volume16lld:pubmed
pubmed-article:16708051pubmed:ownerNLMlld:pubmed
pubmed-article:16708051pubmed:authorsCompleteYlld:pubmed
pubmed-article:16708051pubmed:pagination429-38lld:pubmed
pubmed-article:16708051pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:meshHeadingpubmed-meshheading:16708051...lld:pubmed
pubmed-article:16708051pubmed:year2006lld:pubmed
pubmed-article:16708051pubmed:articleTitleRibonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.lld:pubmed
pubmed-article:16708051pubmed:affiliationCancer Metastasis Research Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seodaemun-Gu, Seoul, Korea.lld:pubmed
pubmed-article:16708051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16708051pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16708051pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16708051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16708051lld:pubmed